65753-600 NDC - CORETEX SUN X 50 ()

Drug Information

  • Product NDC: 65753-600
  • Proprietary Name: CoreTex Sun X 50
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: CoreTex Products Inc
Product Type:
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date:8/16/2019
End Marketing Date:4/4/2023

Package Information

No. Package Code Package Description Billing Unit
165753-600-0130 mL in 1 BOTTLE, PLASTIC (65753-600-01)
265753-600-0260 mL in 1 BOTTLE, PLASTIC (65753-600-02)
365753-600-03118 mL in 1 BOTTLE, PLASTIC (65753-600-03)
465753-600-04177 mL in 1 BOTTLE, PLASTIC (65753-600-04)
565753-600-05237 mL in 1 BOTTLE, PLASTIC (65753-600-05)
665753-600-07473 mL in 1 BOTTLE, PLASTIC (65753-600-07)
765753-600-08473 mL in 1 BAG (65753-600-08)
865753-600-09946 mL in 1 BOTTLE, PLASTIC (65753-600-09)
965753-600-103785 mL in 1 BOTTLE, PLASTIC (65753-600-10)
1065753-600-22175 POUCH in 1 CONTAINER (65753-600-22) / 7 mL in 1 POUCH (65753-600-39)
1165753-600-23350 POUCH in 1 CONTAINER (65753-600-23) / 7 mL in 1 POUCH (65753-600-39)
1265753-600-24350 POUCH in 1 CONTAINER (65753-600-24) / 7 mL in 1 POUCH (65753-600-39)
1365753-600-25700 POUCH in 1 CONTAINER (65753-600-25) / 7 mL in 1 POUCH (65753-600-39)
1465753-600-262100 POUCH in 1 CARTON (65753-600-26) / 7 mL in 1 POUCH (65753-600-39)
1565753-600-3244 mL in 1 BOTTLE, PLASTIC (65753-600-32)
1665753-600-3360 mL in 1 BOTTLE, PLASTIC (65753-600-33)
1765753-600-34118 mL in 1 BOTTLE, PLASTIC (65753-600-34)
1865753-600-397 mL in 1 POUCH (65753-600-39)

NDC Record

Field Name Field Value Definition
PRODUCT NDC65753-600The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMECoreTex Sun X 50The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE8/16/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE4/4/2023This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEOTC MONOGRAPH NOT FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERpart352This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMECoreTex Products IncName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025